1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 3:

Bayesian-derived quantitative analysis of CBF, CBV, and MTT for gray matter and white matter in half-dose (0.05-mmol/kg) and full-dose (0.1-mmol/kg) contrast groupsa

Contrast DoseBayesian-Processed DSC
GMt Test (P Value)WMt Test (P Value)
FDHDFDHD
CBF (mL/100 g/min)75.7 ± 27.062.1 ± 23.2.001b21.6 ± 7.117.9 ± 6.2.037b
CBV (mL/100 g)2.2 ± 0.81.8 ± 0.7.0901.3 ± 0.41.1 ± 0.4.11
MTT (sec)2.9 ± 0.92.7 ± 1.1.4504.3 ± 1.14.8 ± 1.2.051
  • a Data are presented as mean ± SD.

  • b Significant.